Published in J Infect Dis on October 01, 1996
Prevalence of sexually transmitted infections and performance of STI syndromes against aetiological diagnosis, in female sex workers of red light area in Surat, India. Sex Transm Infect (2003) 2.17
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol (1997) 1.90
What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India. Sex Transm Infect (2006) 1.24
The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis. PLoS One (2010) 1.19
Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob Agents Chemother (2000) 1.12
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manuf Serv Oper Manag (2012) 1.08
Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect Dis (2003) 1.04
Neighborhood drug markets: a risk environment for bacterial sexually transmitted infections among urban youth. Soc Sci Med (2012) 1.02
The distribution of people seeking STD services in the various types of health care facilities in Chao Yang District, Beijing, China. Sex Transm Dis (2008) 0.96
Recommendations for increasing the use of HIV/AIDS resource allocation models. BMC Public Health (2009) 0.88
Critical design features of phenyl carboxylate-containing polymer microbicides. Antimicrob Agents Chemother (2006) 0.82
HIV infections and associated costs attributable to syphilis coinfection among African Americans. Am J Public Health (2003) 0.81
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68
The Ebola emergency--immediate action, ongoing strategy. N Engl J Med (2014) 2.80
Combination HIV prevention. Lancet (2008) 2.10
Improving responsiveness of health systems to non-communicable diseases. Lancet (2013) 2.06
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81
Infectious disease: tough choices to reduce Ebola transmission. Nature (2014) 1.77
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
Prevention and control of chronic diseases. BMJ (2010) 1.56
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc (2010) 1.35
Redesigning the AIDS response for long-term impact. Bull World Health Organ (2011) 1.17
Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One (2013) 1.17
Interview with Peter Piot. Interview by Marc Vandenbruaene. Sex Transm Infect (2007) 1.09
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open (2012) 1.01
Scientific evidence alone is not sufficient basis for health policy. BMJ (2012) 1.00
Global public health leadership for the twenty-first century: towards improved health of all populations. Glob Public Health (2012) 0.96
GBD 2.0: a continuously updated global resource. Lancet (2013) 0.96
Setting new standards for targeted HIV prevention: the Avahan initiative in India. Sex Transm Infect (2010) 0.89
UNITAID can address HCV/HIV co-infection. Lancet (2013) 0.87
Health system strengthening in Myanmar during political reforms: perspectives from international agencies. Health Policy Plan (2014) 0.87
The counter effects of the Ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa. AIDS (2016) 0.85
HIV/AIDS prevention and treatment. Lancet (2002) 0.84
Expectations for the United Nations high-level meeting on noncommunicable diseases. Bull World Health Organ (2011) 0.83
Prevention of sexual transmission of HIV: real results, science progressing, societies remaining behind. AIDS (2012) 0.82
A promise to save 100,000 trauma patients. Lancet (2012) 0.81
The evolving HIV/AIDS response and the urgent tasks ahead. Health Aff (Millwood) (2009) 0.80
AIDS is not over. Lancet (2012) 0.79
Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response. PLoS Med (2011) 0.79
The new age of global health governance holds promise. Nat Med (2010) 0.78
Good politics, bad politics: the experience of AIDS. Am J Public Health (2007) 0.78
Peter Piot-executive director of UNAIDS. Interview by Pam Das. Lancet Infect Dis (2003) 0.77
Trends in life expectancy in Europe: one big explanation or many small ones? Eur J Epidemiol (2013) 0.75
HIV/AIDS and human rights: continued commitment in the second decade. Health Hum Rights (1998) 0.75
Straight talk with ... Peter Piot. Nat Med (2010) 0.75
One-on-one with Dr. Peter Piot. Interview by Charles E. Clifton. Posit Aware (2003) 0.75
["Ebola: a major humanitarian crisis that may linger" (Pr Peter Piot)]. Rev Med Suisse (2014) 0.75
The changing landscape of global public health. Glob Public Health (2012) 0.75
Podcast: 10 questions with Dr. Peter Piot. CMAJ (2015) 0.75
Sustaining treatment costs: who will pay? AIDS (2007) 0.75